Aimei Health Technology Co Ltd (AFJK) FinancialsAFJKAimei Health Technology Co Ltd

Evaluating the bottom line, Aimei Health Technology Co Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 1.66%, provide a clear picture of how effectively AFJK converts its operational activities into shareholder value.

In the context of the broader market, AFJK competes directly with industry leaders such as FSHP and DTSQ. With a market capitalization of $38.63M, it holds a significant position in the sector. When comparing efficiency, AFJK's gross margin of N/A stands against FSHP's N/A and DTSQ's N/A. Such benchmarking helps identify whether Aimei Health Technology Co Ltd is trading at a premium or discount relative to its financial performance.

The company's net income has been declining, with a reported net income of -83144 in Q2 2026, and a current ratio of only 0.01, indicating severe liquidity issues. The debt-to-equity ratio has also increased to 27.43%, suggesting a heavy reliance on debt financing.